GlassScriptPhysician profile
Elizabeth A Smith
NPI 1376923938
$1,841.98
in general payments reported to CMS, 2019-2025
27 companies · $219 in 2025
The $219 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.74 · 2020: $130 · 2021: $256 · 2022: $476 · 2023: $407 · 2024: $283 · 2025: $219.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $436.46 | 2020-2024 | Ova1 |
| Abbvie INC. | $229.79 | 2019-2024 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $191.68 | 2023-2024 | Myfembree |
| Organon LLC | $153.48 | 2021-2025 | Nexplanon, Nuvaring |
| Mayne Pharma Commercial LLC | $137.61 | 2023-2025 | |
| Hologic Sales and Service, LLC | $111.57 | 2022-2025 | Coolseal Generator, Novasure, Acessa Provu System |
| Exeltis, USA INC. | $65.98 | 2024-2025 | Slynd |
| Merck Sharp & Dohme LLC | $58.74 | 2019-2023 | Gardasil 9 |
| Molnlycke Health Care US, LLC | $49.62 | 2022 | |
| Coopersurgical, INC. | $46.45 | 2020-2023 | Paragard T 380a |
| Daiichi Sankyo INC. | $44.89 | 2024-2025 | Injectafer |
| Myovant Sciences INC. | $43.26 | 2022 | |
| Evofem Biosciences, INC. | $36.77 | 2021-2022 | |
| Minerva Surgical, INC | $33.46 | 2020 | |
| Therapeuticsmd, INC. | $31.12 | 2021-2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.63 | 2023 | Truclear |
| Exact Sciences Corporation | $19.68 | 2025 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $16.02 | 2022 | |
| Pfizer INC. | $15.54 | 2023 | |
| Agile Therapeutics, INC. | $15.41 | 2021 | |
| Astellas Pharma US INC | $14.44 | 2024 | Veozah |
| Dysis Medical, INC. | $13.27 | 2020 | |
| Medicem INC. | $12.50 | 2020 | |
| Allergan, INC. | $12.34 | 2020 | |
| Duchesnay USA Incorporated | $11.69 | 2019 | |
| Mylan Pharmaceuticals INC. | $11.36 | 2019 | |
| Alydia Health | $4.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.